S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
NASDAQ:PACB

Pacific Biosciences of California (PACB) Earnings Date, Estimates & Call Transcripts

$8.35
-0.01 (-0.12%)
(As of 09/29/2023 ET)
Compare
Today's Range
$8.21
▼
$8.52
50-Day Range
$8.23
▼
$13.50
52-Week Range
$5.45
▼
$14.55
Volume
3.67 million shs
Average Volume
3.83 million shs
Market Capitalization
$2.09 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.10
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Nov. 6Estimated
Actual EPS
(Aug. 2)
-$0.26 Beat By $0.06
Consensus EPS
(Aug. 2)
-$0.32
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

PACB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PACB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Pacific Biosciences of California Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20231($0.30)($0.30)($0.30) 
Q2 20231($0.30)($0.30)($0.30) 
Q3 20232($0.30)($0.28)($0.29) 
Q4 20232($0.31)($0.26)($0.29) 
FY 20236($1.21)($1.14)($1.18) 
Q1 20241($0.29)($0.29)($0.29) 
Q3 20241($0.26)($0.26)($0.26) 
Q4 20241($0.27)($0.27)($0.27) 
20243($0.82)($0.82)($0.82) 
Q1 20251($0.22)($0.22)($0.22) 
Q2 20251($0.22)($0.22)($0.22) 

PACB Earnings Date and Information

Pacific Biosciences of California last released its quarterly earnings results on August 2nd, 2023. The biotechnology company reported ($0.26) earnings per share for the quarter, beating analysts' consensus estimates of ($0.32) by $0.06. The company had revenue of $47.57 million for the quarter, compared to analyst estimates of $40.12 million. Its revenue for the quarter was up 34.1% compared to the same quarter last year. Pacific Biosciences of California has generated ($1.35) earnings per share over the last year (($1.35) diluted earnings per share). Earnings for Pacific Biosciences of California are expected to grow in the coming year, from ($1.18) to ($1.01) per share. Pacific Biosciences of California has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 6th, 2023 based off prior year's report dates.

Pacific Biosciences of California Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/6/2023
Estimated)		------- 
8/2/2023Q2 2023($0.32)($0.26)+$0.06($0.24)$40.12 million$47.57 million    
5/2/2023Q1 2023($0.33)($0.31)+$0.02($0.26)$34.38 million$38.90 million      
2/16/2023Q4 2022($0.34)($0.35)($0.01)($0.33)$27.29 million$27.35 million    
11/7/2022Q3 2022($0.35)($0.32)+$0.03($0.30)$35.30 million$32.31 million
8/3/2022Q2 2022($0.34)($0.34)-($0.36)$35.54 million$35.47 million    
5/4/2022Q1 2022($0.32)($0.37)($0.05)($0.37)$32.82 million$33.17 million      
2/15/2022Q4 2021($0.28)($0.30)($0.02)($0.29)$36.00 million$36.02 million    
11/2/2021Q3 2021($0.22)($0.23)($0.01)($0.54)$32.93 million$34.89 million    
8/2/2021Q2 2021($0.21)($0.21)-($0.21)$30.46 million$30.61 million    
4/29/2021Q1 2021($0.45)($0.18)+$0.27$0.09$25.66 million$29.00 million  
2/9/2021Q4 2020$0.43$0.37($0.06)($0.39)$25.54 million$27.10 million  
11/7/2020Q3 2020($0.13)($0.14)($0.01)($0.14)$20.40 million$19.08 million    












Pacific Biosciences of California Earnings - Frequently Asked Questions

When is Pacific Biosciences of California's earnings date?

Pacific Biosciences of California has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 6th, 2023 based off last year's report dates. Learn more on PACB's earnings history.

Did Pacific Biosciences of California beat their earnings estimates last quarter?

In the previous quarter, Pacific Biosciences of California (NASDAQ:PACB) reported ($0.26) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.32) by $0.06. Learn more on analysts' earnings estimate vs. PACB's actual earnings.

How can I listen to Pacific Biosciences of California's earnings conference call?

The conference call for Pacific Biosciences of California's latest earnings report can be listened to online. Listen to Conference Call

How can I read Pacific Biosciences of California's conference call transcript?

The conference call transcript for Pacific Biosciences of California's latest earnings report can be read online. Read Transcript

How much revenue does Pacific Biosciences of California generate each year?

Pacific Biosciences of California (NASDAQ:PACB) has a recorded annual revenue of $128.30 million.

How much profit does Pacific Biosciences of California generate each year?

Pacific Biosciences of California (NASDAQ:PACB) has a recorded net income of -$314.25 million. PACB has generated -$1.35 earnings per share over the last four quarters.

What is Pacific Biosciences of California's EPS forecast for next year?

Pacific Biosciences of California's earnings are expected to grow from ($1.18) per share to ($1.01) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:PACB) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -